This HP Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
1
0
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
- Wolfe Research analyst Andy Chen downgraded the rating for Celldex Therapeutics, Inc. (NASDAQ:CLDX) from Outperform to Peer Perform. Celldex Therapeutics shares fell 8.7% to close at $32.86 on Thursday. See how other analysts view this stock.
- Keybanc analyst Justin Patterson downgraded Bumble Inc. (NASDAQ:BMBL) from Overweight to Sector Weight. Bumble shares gained 1.9% to close at $6.44 on Thursday. See how other analysts view this stock.
- B of A …
Full story available on Benzinga.com
Visited 1 times, 1 visit(s) today
Related posts:
- Home Run To Homewrecker – Analyst Cautious On Homebuilders, Downgrades Key Players
- Aclaris Therapeutics’ ATI-1777 Faces Uphill Battle In Atopic Dermatitis Treatment Landscape, Analyst Downgrades
- Archer-Daniels-Midland’s Financial Figures ‘Are Too High,’ Analyst Downgrades Stock
- After 130% Surge, AMD Faces Uncertain Road Ahead: Top Analyst Says Chipmaker’s Future Shrouded In Doubt